Business Context and Reporting Period
Company: Core Scientific, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: August 13, 2024 (Event Date: August 19, 2024)
Context: The Company announced and completed a private offering of convertible senior notes to refinance existing debt and fund general corporate purposes.
Key Financial Metrics and Capital Structure
- New Debt Issuance: $460.0 million aggregate principal amount of 3.00% Convertible Senior Notes due 2029.
- Net Proceeds: Approximately $445.0 million (after discounts, commissions, and expenses).
- Interest Rate: 3.00% per annum, payable semi-annually starting March 1, 2025.
- Maturity Date: September 1, 2029.
- Conversion Terms: Initial conversion price of approximately $11.00 per share (90.9256 shares per $1,000 principal amount).
- Debt Repayment:
- $61.2 million used to repay outstanding loans under the credit and guaranty agreement dated January 23, 2024.
- $150.0 million used to redeem all outstanding 12.50% Secured Notes due 2028.
- Remaining Proceeds: Intended for working capital, operating expenses, capital expenditures, acquisitions, or share repurchases.
Material Changes Versus Prior Period
This filing represents a significant capital structure change rather than a periodic financial performance report. Key changes include:
- Debt Refinancing: Replacement of high-interest debt (12.50% Secured Notes) with lower-cost convertible debt (3.00% Notes).
- Liquidity Improvement: Generation of approximately $445.0 million in net cash proceeds.
- Dilution Potential: Up to 54,373,518 shares of Common Stock may be issued upon conversion of the Notes.
Guidance, Outlook, Risks, and Contingencies
- Redemption Rights: The Company may redeem the Notes on or after September 7, 2027, subject to liquidity conditions and stock price thresholds (130% of conversion price).
- Make-Whole Provisions: Conversion rates may increase in the event of a "Make-Whole Fundamental Change" or if the Company calls the Notes for redemption.
- Events of Default: Includes payment defaults, failure to convert, bankruptcy, and defaults on other indebtedness exceeding $25 million. Bankruptcy events trigger immediate acceleration of all Notes.
- Unregistered Securities: The Notes were issued under Section 4(a)(2) and Rule 144A exemptions; shares issued upon conversion will be exempt under Section 3(a)(9).
Investor Verification Checklist
- Verify the exact amount of cash remaining after the $211.2 million debt repayments to assess immediate liquidity impact.
- Review the Indenture (Exhibit 4.1) for specific definitions of "Fundamental Change" and "Make-Whole Fundamental Change" to understand dilution risks.
- Confirm the status of the 12.50% Secured Notes redemption scheduled for September 3, 2024.
- Monitor the Company's stock price relative to the $11.00 conversion price to assess the likelihood of conversion versus cash settlement.
- Check for any subsequent filings regarding the use of remaining proceeds for acquisitions or share repurchases.